Subcutaneous injection with an insulin pen. Insulin absorption and plasma concentrations of glucose and free insulin. 1990

P H de Meijer, and J A Lutterman
Department of Medicine (Division of General Internal Medicine), University of Nijmegen.

In 6 type 1 diabetic patients treated with a basal-prandial injection regimen with a pen, plasma concentrations of free insulin and glucose were measured over a period of 24 h. We obtained an insulin peak 1 h after injection of regular insulin and lower levels at night. Between peaks, basal levels of free insulin were not reached. Glucose concentrations fluctuated only slightly. In 10 healthy volunteers, the absorption rate of insulin was studied after subcutaneous injection of 125I-Actrapid using a conventional technique and with a pen. During an 8-h period residual radioactivity and plasma insulin and glucose were measured. No significant differences were found, except for the insulin concentration 60 min after injection (higher after pen injection, P less than 0.05). The variability of the parameters was greater following pen injection (P less than 0.02). A basal-prandial injection regimen can thus produce stable glucose levels but only with considerable hyperinsulinaemia. Injection with an insulin pen causes a modest increase in absorption rate and plasma concentrations of insulin.

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000042 Absorption The physical or physiological processes by which substances, tissue, cells, etc. take up or take in other substances or energy.
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

P H de Meijer, and J A Lutterman
March 1990, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
P H de Meijer, and J A Lutterman
April 1993, Lancet (London, England),
P H de Meijer, and J A Lutterman
August 2013, Computer methods and programs in biomedicine,
P H de Meijer, and J A Lutterman
June 1980, British medical journal,
Copied contents to your clipboard!